Reorganization of the actin cytoskeleton in airway smooth muscle

Information

  • Research Project
  • 10113413
  • ApplicationId
    10113413
  • Core Project Number
    R01HL110951
  • Full Project Number
    5R01HL110951-08
  • Serial Number
    110951
  • FOA Number
    PA-18-484
  • Sub Project Id
  • Project Start Date
    12/1/2011 - 12 years ago
  • Project End Date
    3/31/2023 - a year ago
  • Program Officer Name
    LU, JINING
  • Budget Start Date
    4/1/2021 - 3 years ago
  • Budget End Date
    3/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    08
  • Suffix
  • Award Notice Date
    3/25/2021 - 3 years ago
Organizations

Reorganization of the actin cytoskeleton in airway smooth muscle

Airway smooth muscle cell proliferation plays an important role in the pathogenesis of airway smooth muscle layer thickening, cardinal features of asthma that affects nearly 250 million people worldwide. In addition, bronchial biopsy of patients with severe asthma suggests that airway smooth muscle migration contributes to smooth muscle thickening in the airways. The mechanisms that regulate smooth muscle cell proliferation and migration are not fully elucidated. Abi1 (Abl interactor 1) is an adapter protein that has a role in actin cytoskeletal remodeling in nonmuscle cells and smooth muscle contraction. Nevertheless, the role and mechanisms of Abi1 in smooth muscle cell proliferation and migration have not been previously investigated. Pilot studies have shown that Abi1 knockdown attenuates DNA synthesis and cell numbers enhanced by platelet-derived growth factor (PDGF), suggesting an important role of Abi1 in regulating airway smooth muscle cell proliferation. In Aim 1, the role of Abi1 in regulating the Jak2 and STAT3 phosphorylation, and other pathways will be evaluated in cells upon stimulation with growth factors. In Aim 2, the role of Abi1 in airway smooth muscle migration and its effectors will be evaluated. In Aim 3, the role of Abi1 in allergen- induced airway smooth muscle thickening will be evaluated by using conditional Abi1 knockout mice. Moreover, the potential role of Abi1-associated pathways in human asthma will be determined. Completion of these studies should advance our knowledge regarding functional role and mechanism of the adapter protein Abi1 in smooth muscle cell proliferation and migration in vitro, and asthma pathogenesis in vivo. Obtaining this knowledge will facilitate the development of new therapy to treat asthma.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R01
  • Administering IC
    HL
  • Application Type
    5
  • Direct Cost Amount
    250000
  • Indirect Cost Amount
    155000
  • Total Cost
    405000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    838
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NHLBI:405000\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    LCMI
  • Study Section Name
    Lung Cellular, Molecular, and Immunobiology Study Section
  • Organization Name
    ALBANY MEDICAL COLLEGE
  • Organization Department
    OTHER BASIC SCIENCES
  • Organization DUNS
    190592162
  • Organization City
    ALBANY
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    122083479
  • Organization District
    UNITED STATES